Cannapharmarx (PK) Stock Price

-0.009 (-2.43%)
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cannapharmarx Inc (PK) CPMD OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.009 -2.43% 0.361 13:30:11
Open Price Low Price High Price Close Price Previous Close
0.36 0.36 0.42 0.37
Bid Price Ask Price Spread News
0.355 0.55 0.195 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
16 3,082 $ 0.376027 $ 1,159 130,281 0.0331 - 2.60
Last Trade Time Type Quantity Stock Price Currency
12:58:30 100 $ 0.361 USD

Cannapharmarx (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 15.90M 44.04M 838.29k $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
3.55k $ - 0.00% - -

more financials information »

Cannapharmarx (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CPMD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.350.420.350.386472766,2520.0113.14%
1 Month0.450.450.350.394368941,723-0.089-19.78%
3 Months1.101.100.350.5887358122,571-0.739-67.18%
6 Months1.582.600.350.892323381,681-1.22-77.15%
1 Year1.752.600.03310.891691652,947-1.39-79.37%
3 Years0.277754.000.03310.939450121,7790.0832529.97%
5 Years1.444.000.03310.932324816,475-1.08-74.93%

Cannapharmarx (PK) Description

CannaPharmaRx, Inc. is an early-stage pharmaceutical company whose purpose is to advance cannabinoid research and discovery using proprietary formulation and drug delivery technology currently in development. Cannabinoids are a class of chemicals that, once ingested, are active in humans and animals through the "endocannabinoid system" -- one of the most widely expressed system of receptors in the human body. CannaPharmaRx is currently focused on targeting disease states where its delivery systems can have optimal impact with therapeutic differentiation among alternative cannabinoid therapies, including: neurological disorders, oncology, infectious disease, pain management, inflammatory disease, gastrointestinal disorders and ophthalmology.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.